{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:25:27Z","timestamp":1790997927366,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T00:00:00Z","timestamp":1786060800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK118431"],"award-info":[{"award-number":["R01DK118431"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Office of Research and Development","doi-asserted-by":"publisher","award":["LPOP-L0021"],"award-info":[{"award-number":["LPOP-L0021"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["75N92022D00015"],"award-info":[{"award-number":["75N92022D00015"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL158071 - 01A1"],"award-info":[{"award-number":["R01HL158071 - 01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009224","name":"Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["D25CA00140-00"],"award-info":[{"award-number":["D25CA00140-00"]}],"id":[{"id":"10.13039\/100009224","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015854","name":"Scott R. MacKenzie Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015854","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018154","name":"Fund for Innovation in Cancer Informatics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018154","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100028310","name":"Institute for Technology in Health Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100028310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011621","name":"Winship Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001299","name":"Prevent Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001299","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG089759"],"award-info":[{"award-number":["R01AG089759"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA249992 - 01A1"],"award-info":[{"award-number":["R01CA249992 - 01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA138292"],"award-info":[{"award-number":["P30CA138292"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA269181 - 01"],"award-info":[{"award-number":["U01CA269181 - 01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA264017 - 01"],"award-info":[{"award-number":["R01CA264017 - 01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA257612 - 01A1"],"award-info":[{"award-number":["R01CA257612 - 01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U01CA113913 - 16A1"],"award-info":[{"award-number":["U01CA113913 - 16A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA268287 - 01A1"],"award-info":[{"award-number":["R01CA268287 - 01A1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA268207-01"],"award-info":[{"award-number":["R01CA268207-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U54CA302465-01"],"award-info":[{"award-number":["U54CA302465-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA274494-01"],"award-info":[{"award-number":["U24CA274494-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["I01CX002776"],"award-info":[{"award-number":["I01CX002776"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["IK6BX006185"],"award-info":[{"award-number":["IK6BX006185"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007496","name":"Biomedical Laboratory Research and Development, VA Office of Research and Development","doi-asserted-by":"publisher","award":["I01CX002622"],"award-info":[{"award-number":["I01CX002622"]}],"id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000092","name":"National Library of Medicine","doi-asserted-by":"publisher","award":["R01LM013864 - 01A1"],"award-info":[{"award-number":["R01LM013864 - 01A1"]}],"id":[{"id":"10.13039\/100000092","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI175555 - 01A1"],"award-info":[{"award-number":["R01AI175555 - 01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01HL151277 - 01A1"],"award-info":[{"award-number":["R01HL151277 - 01A1"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IBX004121"],"award-info":[{"award-number":["IBX004121"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1OT2OD038065-01"],"award-info":[{"award-number":["1OT2OD038065-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejca.2026.116979","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T23:35:15Z","timestamp":1786145715000},"page":"116979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A stromal\u2013immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study"],"prefix":"10.1016","volume":"246","author":[{"given":"Bolin","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-0337","authenticated-orcid":false,"given":"Himanshu","family":"Maurya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Tokuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal","family":"Hammouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4918-2733","authenticated-orcid":false,"given":"Ibrahim","family":"Mohammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9738-4172","authenticated-orcid":false,"given":"Tilak","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viraj A.","family":"Master","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Asim","family":"Bilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilpa","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hexiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5741-0399","authenticated-orcid":false,"given":"Anant","family":"Madabhushi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ejca.2026.116979_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.ejca.2026.116979_bib2","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.ejca.2026.116979_bib3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.eururo.2012.02.028","article-title":"Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients","volume":"61","author":"Hautmann","year":"2012","journal-title":"Eur Urol"},{"issue":"22","key":"10.1016\/j.ejca.2026.116979_bib4","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ejca.2026.116979_bib5","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1056\/NEJMoa2312117","article-title":"EV-302 Trial Investigators. Enfortumab vedotin and pembrolizumab in untreated advanced urothelial cancer","volume":"390","author":"Powles","year":"2024","journal-title":"N Engl J Med"},{"issue":"7_","key":"10.1016\/j.ejca.2026.116979_bib6","article-title":"Neoadjuvant and adjuvant enfortumab vedotin (EV) plus pembrolizumab (pembro) for participants with muscle-invasive bladder cancer (MIBC) who are eligible for cisplatin: Randomized, open-label, phase 3 KEYNOTE-B15 study","volume":"44","author":"Galsky","year":"2026","journal-title":"J Clin Oncol"},{"issue":"10064","key":"10.1016\/j.ejca.2026.116979_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"IMvigor210 Study Group. Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1186\/s12885-016-2361-7","article-title":"Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models","volume":"16","author":"L\u00f3pez de Maturana","year":"2016","journal-title":"BMC Cancer"},{"issue":"18","key":"10.1016\/j.ejca.2026.116979_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1200\/JCO.18.02052","article-title":"Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free dna in patients with urothelial bladder carcinoma","volume":"37","author":"Christensen","year":"2019","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.ejca.2026.116979_bib10","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","article-title":"A consensus molecular classification of muscle-invasive bladder cancer","volume":"77","author":"Kamoun","year":"2020","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.ejca.2026.116979_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2026.116979_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103054","article-title":"Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer","volume":"61","author":"Zhao","year":"2020","journal-title":"EBioMedicine"},{"issue":"10","key":"10.1016\/j.ejca.2026.116979_bib13","article-title":"Deciphering the morphology of tumor-stromal features in invasive breast cancer using artificial intelligence","volume":"36","author":"Atallah","year":"2023","journal-title":"Mod Pathol J U S Can Acad Pathol Inc"},{"key":"10.1016\/j.ejca.2026.116979_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105152","article-title":"Impact of tumour stroma-immune interactions on survival prognosis and response to neoadjuvant chemotherapy in bladder cancer","volume":"104","author":"Liu","year":"2024","journal-title":"EBioMedicine"},{"issue":"12","key":"10.1016\/j.ejca.2026.116979_bib15","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.3390\/cancers12123749","article-title":"Tumour stroma ratio assessment using digital image analysis predicts survival in triple negative and luminal breast cancer","volume":"12","author":"Millar","year":"2020","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.ejca.2026.116979_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s13402-019-00429-z","article-title":"Computer aided quantification of intratumoral stroma yields an independent prognosticator in rectal cancer","volume":"42","author":"Geessink","year":"2019","journal-title":"Cell Oncol"},{"issue":"5","key":"10.1016\/j.ejca.2026.116979_bib17","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1078-0432.CCR-18-2013","article-title":"Spatial architecture and arrangement of tumor-infiltrating lymphocytes for predicting likelihood of recurrence in early-stage non-small cell lung cancer","volume":"25","author":"Corredor","year":"2019","journal-title":"Clin Cancer Res J Am Assoc Cancer Res"},{"issue":"7948","key":"10.1016\/j.ejca.2026.116979_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","article-title":"Single-cell spatial landscapes of the lung tumour immune microenvironment","volume":"614","author":"Sorin","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2026.116979_bib19","unstructured":"Proliferation- and immune-informed fusion of multiscale image features for bladder cancer prognosis. | Journal of Clinical Oncology [Internet]. [cited 2026 May 8]. Available from: https:\/\/ascopubs.org\/doi\/abs\/10.1200\/JCO.2026.44.7_suppl.802."},{"issue":"7","key":"10.1016\/j.ejca.2026.116979_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410998","article-title":"Tertiary lymphoid structures are linked to enhanced antitumor immunity and better prognosis in muscle-invasive bladder cancer","volume":"12","author":"Lin","year":"2025","journal-title":"Adv Sci"},{"issue":"9","key":"10.1016\/j.ejca.2026.116979_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107635","article-title":"Computerized tertiary lymphoid structures density on H&E-images is a prognostic biomarker in resectable lung adenocarcinoma","volume":"26","author":"Wang","year":"2023","journal-title":"iScience"},{"issue":"7","key":"10.1016\/j.ejca.2026.116979_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2024.102071","article-title":"Prognostic effect of tertiary lymphoid structures in Epstein-Barr virus-associated gastric carcinomas measured by digital image analysis","volume":"104","author":"Cho","year":"2024","journal-title":"Lab Investig J Tech Methods Pathol"},{"issue":"10","key":"10.1016\/j.ejca.2026.116979_bib23","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-012374","article-title":"Artificial intelligence-powered spatial analysis of tumor microenvironment in patients with non-small cell lung cancer with acquired resistance to EGFR tyrosine kinase inhibitor","volume":"13","author":"Bang","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41392-024-01947-5","article-title":"Tertiary lymphoid structures in diseases: immune mechanisms and therapeutic advances","volume":"9","author":"Zhao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib25","doi-asserted-by":"crossref","first-page":"8673","DOI":"10.1038\/s41467-025-63696-5","article-title":"Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy","volume":"16","author":"Schmid","year":"2025","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ejca.2026.116979_bib26","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.ijrobp.2025.09.056","article-title":"The clinical relevance of tertiary lymphoid structures in assessing treatment response in muscle-invasive bladder cancer","volume":"124","author":"Hassan","year":"2026","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"10.1016\/j.ejca.2026.116979_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41571-019-0252-y","article-title":"Artificial intelligence in digital pathology \u2014 new tools for diagnosis and precision oncology","volume":"16","author":"Bera","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116979_bib28","first-page":"61","article-title":"HoVer-NeXt: a fast nuclei segmentation and classification pipeline for next generation histopathology","author":"Baumann","year":"2024","journal-title":"Proc 7nd Int Conf Med Imaging Deep Learn PMLR"},{"key":"10.1016\/j.ejca.2026.116979_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v091.i01","article-title":"dbscan: fast density-based clustering with R","volume":"91","author":"Hahsler","year":"2019","journal-title":"J Stat Softw"},{"key":"10.1016\/j.ejca.2026.116979_bib30","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s43856-022-00186-5","article-title":"TIAToolbox as an end-to-end library for advanced tissue image analytics","volume":"2","author":"Pocock","year":"2022","journal-title":"Commun Med"},{"issue":"7","key":"10.1016\/j.ejca.2026.116979_bib31","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41571-022-00619-z","article-title":"B cells and tertiary lymphoid structures as determinants of tumour immune contexture and clinical outcome","volume":"19","author":"Fridman","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.ejca.2026.116979_bib32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinforma"},{"issue":"5","key":"10.1016\/j.ejca.2026.116979_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100154","article-title":"High interobserver variability among pathologists using combined positive score to evaluate PD-L1 expression in gastric, gastroesophageal junction, and esophageal adenocarcinoma","volume":"36","author":"Robert","year":"2023","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11934-025-01314-z","article-title":"The emerging role of b cells and tertiary lymphoid structures in bladder cancer","volume":"27","author":"Penunuri","year":"2026","journal-title":"Curr Urol Rep"},{"key":"10.1016\/j.ejca.2026.116979_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1235884","article-title":"The bladder cancer immune micro-environment in the context of response to immune checkpoint inhibition","volume":"14","author":"van Dorp","year":"2023","journal-title":"Front Immunol"},{"issue":"7693","key":"10.1016\/j.ejca.2026.116979_bib36","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41698-024-00533-w","article-title":"Tertiary lymphoid structures predict survival and response to neoadjuvant therapy in locally advanced rectal cancer","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010173","article-title":"Comparative impact of tertiary lymphoid structures and tumor-infiltrating lymphocytes in cholangiocarcinoma","volume":"13","author":"Chung","year":"2025","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.52553","article-title":"Development and validation of a machine learning model for detection and classification of tertiary lymphoid structures in gastrointestinal cancers","volume":"6","author":"Li","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"22","key":"10.1016\/j.ejca.2026.116979_bib40","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abn3966","article-title":"Spatial interplay patterns of cancer nuclei and tumor-infiltrating lymphocytes (TILs) predict clinical benefit for immune checkpoint inhibitors","volume":"8","author":"Wang","year":"2022","journal-title":"Sci Adv"},{"key":"10.1016\/j.ejca.2026.116979_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218134","article-title":"A deep learning framework to Identify Prognostically Relevant Cancer Regions (DOVER) within whole slide histopathology images","volume":"636","author":"Wang","year":"2026","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.ejca.2026.116979_bib42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41523-021-00310-z","article-title":"Collagen fiber orientation disorder from H&E images is prognostic for early stage breast cancer: clinical trial validation","volume":"7","author":"Li","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.ejca.2026.116979_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.media.2020.101903","article-title":"Feature-driven local cell graph (FLocK): new computational pathology-based descriptors for prognosis of lung cancer and HPV status of oropharyngeal cancers","volume":"68","author":"Lu","year":"2021","journal-title":"Med Image Anal"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804926007604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T16:09:25Z","timestamp":1789056565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804926007604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":43,"alternative-id":["S0959804926007604"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116979","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A stromal\u2013immune computational pathology signature for prognosis and immune checkpoint inhibitor response in localized, locally advanced and metastatic urothelial carcinoma: A multicenter retrospective study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2026.116979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"116979"}}